Endocrine Abstracts

Glucose flash monitoring, which continuously records the glucose level in the interstitial fluid, is increasingly used to assess glycemia.The aim of the study was to evaluate the effectiveness of flash glucose monitoring in patients with diabetes hospitalized in intensive care units, surgical profile (purulent surgery) and endocrinology. The variability of glycemia, the time spent in the target range, above and below the target range, the frequency and duration of hypo- and hyperglycemic episodes, the effect on the effectiveness of inpatient treatment, and the frequency of repeated hospitalizations were evaluated. The study included 140 patients divided into 3 groups who were hospitalized in intensive care units, endocrinology and purulent surgery. Flash monitoring of glycemia compared with the laboratory test method and glucose measurement allowed to reduce the time spent in a state of hypo- and hyperglycemia, achieve lower variability, and also contributed to a longer maintenance of the target glucose level. After discharge from the medical facility, patients using flash glucose monitoring did not need to be readmitted to the hospital. As a result of the study, patients with type 1 and type 2 diabetes who were hospitalized in the departments of endocrinology, purulent surgery and intensive care, and who used flash monitoring of glycemia, had a more significant improvement in metabolic control compared with laboratory determination and glucometry. In the intensive care unit, the number of blood samples and the time for determining blood glucose were reduced tenfold. Although in real clinical practice it was not possible to fully achieve the recommended time targets in the target ranges and glycemic variability, better values were obtained in patients with flash glucose monitoring; thus, it was possible to avoid the development of acute complications of diabetes mellitus, repeated hospitalizations and reduce hospital stays.